The critical genetic event in CML is the formation of a BCR-ABL fusion gene through a chromosomal translocation between chromosomes 9 and 22, which is found in more than 90% of CML patients [2]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.